Login to Your Account

Vertex: 'Trust the Science'

Hope to Ditch Interferon Has Side Effects for Trials

By Anette Breindl
Science Editor

Monday, November 14, 2011

SAN FRANCISCO – Good science, it is said, brings more questions along with its answers. And by that standard, too, the results from Pharmasset Inc.'s ELECTRON Phase II trial of PSI-7977 presented at the annual meeting of the American Association for the Study of Liver Disease (AASLD) last week were impressive.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription